A

Ackermans & van Haaren

53 employees

Ackermans & van Haaren is a diversified group active in 5 key sectors: infrastructure and marine engineering, private banking, real estate.

Investor insights

Sectors invested in

Health Care7

B2B4

Marketplace4

Medical Device4

Biotechnology4

Medical Equipment4

Medical Supply4

Physiotherapy & Fitness Equipment4

Dentistry4

Safety & Security4

Hospital Furnitures4

Medical Aids4

Online Medical Supply4

Medical Devices4

Medical Consumables4

biomarker testing2

Health Diagnostics2

genomics2

bioinformatics2

precision medicine2

Funding rounds participated in

$21M sweet spot round size

Most of their 9 investments are in rounds between $8.6M and $39M

Investor type

Private Equity Firm

Basic info

Industry

investment management

Sectors

Real Estate

Banking

Infrastructure

Date founded

1876

Investments made

A

AstriVax raised $30M on August 25, 2022

Investors: KU Leuven Innovation & Entrepreneurship, V-Bio Ventures, Merieux Equity Partners, Thuja Capital, BNP Paribas Fortis, FundPlus and Ackermans & van Haaren

M

Medikabazaar raised $64M on April 12, 2022

Investors: HealthQuad, CDC Group plc, Lighthouse Funds and Ackermans & van Haaren

M

Medikabazaar raised $58M on September 22, 2021

Investors: 三井住友海上キャピタル（株）, HealthQuad, CDC Group plc, Catalytic Impact Foundation, - and Ackermans & van Haaren

M

Medikabazaar raised $3.4M on June 18, 2020

Investors: Ackermans & van Haaren

M

MRM Health raised $15M on February 19, 2020

Investors: Qbic, Danisco India Pvt. Ltd., VIB and Ackermans & van Haaren

O

OncoDNA, The Cancer Theranostic Company raised $21M on February 14, 2020

Investors: -, SRIW, CPH Bank, Vesalius Biocapital, SFPI-FPIM and Ackermans & van Haaren

M

Medikabazaar raised $15M on November 18, 2019

Investors: 三井住友海上キャピタル（株）, HealthQuad, Elan Pharmaceuticals, TOPPAN PRINTING CO., LTD. / 凸版印刷株式会社 and Ackermans & van Haaren

B

Biotalys NV raised $39M on July 30, 2019

Investors: Gimv, Qbic, VIB, Sofinnova Partners and Ackermans & van Haaren

O

OncoDNA, The Cancer Theranostic Company raised $8.6M on September 2, 2016

Investors: Inventures Investment Partners, impact Venture Capital and Ackermans & van Haaren